86 related articles for article (PubMed ID: 9014423)
1. [Guidelines of drug therapies for Parkinson's disease].
Yanagisawa N
Nihon Rinsho; 1997 Jan; 55(1):52-7. PubMed ID: 9014423
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Parkinson's disease with multiple drugs].
Kuno S
Nihon Rinsho; 1997 Jan; 55(1):59-64. PubMed ID: 9014424
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
Coelho M; Ferreira J; Rosa M; Sampaio C
Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
[TBL] [Abstract][Full Text] [Related]
4. [New therapeutic strategy for Parkinson's disease based on pharmacological profiles].
Ogawa N
Nihon Rinsho; 1997 Jan; 55(1):43-51. PubMed ID: 9014422
[TBL] [Abstract][Full Text] [Related]
5. Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia.
Stacy M; Galbreath A
Clin Neuropharmacol; 2008; 31(1):51-6. PubMed ID: 18303491
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Parkinson's disease.
Hely MA; Fung VS; Morris JG
J Clin Neurosci; 2000 Nov; 7(6):484-94. PubMed ID: 11029227
[TBL] [Abstract][Full Text] [Related]
7. [Initial treatment of Parkinson's disease].
Kulisevsky J; López-Villegas D
Rev Neurol; 1997 Aug; 25 Suppl 2():S163-9. PubMed ID: 9280684
[TBL] [Abstract][Full Text] [Related]
8. Ropinirole therapy for Parkinson's disease.
Pahwa R; Lyons KE; Hauser RA
Expert Rev Neurother; 2004 Jul; 4(4):581-8. PubMed ID: 15853577
[TBL] [Abstract][Full Text] [Related]
9. [Drug therapy of patients with early-stage parkinson's disease].
Kondo T
Nihon Rinsho; 2000 Oct; 58(10):2055-60. PubMed ID: 11068446
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for early Parkinson's disease.
Stacy M; Brownlee HJ
Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of advanced Parkinson's disease].
Momose Y; Murata M; Kanazawa I
Nihon Rinsho; 2000 Oct; 58(10):2061-5. PubMed ID: 11068447
[TBL] [Abstract][Full Text] [Related]
12. [The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life].
Klivényi P; Vécsei L
Ideggyogy Sz; 2008 Jan; 61(1-2):42-8. PubMed ID: 18372774
[TBL] [Abstract][Full Text] [Related]
13. [Management of autonomic dysfunction in Parkinson's disease].
Crespo-Burillo JA; Alarcia-Alejos R
Rev Neurol; 2015 Apr; 60(8):355-64. PubMed ID: 25857860
[TBL] [Abstract][Full Text] [Related]
14. Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities.
Jenner P
Mov Disord; 2008; 23 Suppl 3():S585-98. PubMed ID: 18781676
[TBL] [Abstract][Full Text] [Related]
15. Should levodopa be used anymore?
Zegers de Beyl D
Acta Neurol Belg; 2002 Dec; 102(4):163-6. PubMed ID: 12534242
[TBL] [Abstract][Full Text] [Related]
16. [Management of Parkinson's disease in 2009].
Maertens de Noordhout A
Rev Med Suisse; 2009 Aug; 5(214):1650-5. PubMed ID: 19772196
[TBL] [Abstract][Full Text] [Related]
17. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease: drug therapy.
Oertel WH; Quinn NP
Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
[TBL] [Abstract][Full Text] [Related]
19. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.
Encarnacion EV; Hauser RA
Eur Neurol; 2008; 60(2):57-66. PubMed ID: 18480609
[TBL] [Abstract][Full Text] [Related]
20. Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum?
Melamed E
J Neural Transm Suppl; 1995; 45():57-60. PubMed ID: 8748609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
